Strategic Generics

Auburn-based Vitruvias develops lower-cost generic drugs and profits by pinpointing niches in the health spectrum. Its location takes advantage of talent from Auburn University and its School of Pharmacy.

By
Bill Gerdes
-

Carl Whatley, CEO of Vitruvias, brings years of experience in the pharmaceutical industry to his new company. Photos by Julie Bennett Last fall, the pharmaceutical industry hit bottom in a public opinion poll, ranking last in Gallup’s list of 25 industries, finishing behind even the federal government. Net ratings for pharma…

Thank you for reading!

To continue reading this article you must be registered and logged into this site. If you already have an account please login now, otherwise you can click here to register for new account. Registration is FREE.

Login       Register

RELATED ARTICLESMORE FROM AUTHOR